Predictors of pathological complete response to neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma

被引：0
|
作者：
Ren-Wen Huang
Yin-Kai Chao
Yu-Wen Wen
Hsien-Kun Chang
Chen-Kan Tseng
Sheng-Chieh Chan
Yun-Hen Liu
机构：
[1] Chang Gung University,Department of Plastic and Reconstructive Surgery, Chang Gung Memorial Hospital, Linkou, College of Medicine
[2] Chang Gung University,Division of Thoracic and Cardiovascular Surgery, Chang Gung Memorial Hospital, Linkou, College of Medicine
[3] Chang Gung University,Clinical Informatics and Medical Statistics Research Center
[4] Chang Gung University,Division of Hematology/Oncology, Chang Gung Memorial Hospital, Linkou, College of Medicine
[5] Chang Gung University,Department of Radiation Oncology, Chang Gung Memorial Hospital, Linkou, College of Medicine
[6] Chang Gung University,Department of Nuclear Medicine, Chang Gung Memorial Hospital, Keelung, College of Medicine
来源：
World Journal of Surgical Oncology | / 12卷
关键词：
Pathological complete response; Esophageal cancer; Predictors; Neoadjuvant chemoradiotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Predictors for recurrence after initial clinical complete response to definitive chemoradiotherapy in esophageal squamous cell carcinoma patients
    Chao, Y. K.
    Chang, H-K.
    Tseng, C. K.
    ANNALS OF ONCOLOGY, 2016, 27
  • [22] CT-based delta-radiomics nomogram to predict pathological complete response after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma patients
    Fan, Liyuan
    Yang, Zhe
    Chang, Minghui
    Chen, Zheng
    Wen, Qiang
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [23] Neoadjuvant Chemoradiotherapy vs Chemoimmunotherapy for Esophageal Squamous Cell Carcinoma
    Guo, Xufeng
    Chen, Chunji
    Zhao, Jinbo
    Wang, Changchun
    Mei, Xinyu
    Shen, Jianfei
    Lv, Huilai
    Han, Yongtao
    Wang, Qifeng
    Lv, Jiahua
    Chen, Hainan
    Yan, Xiaolong
    Liu, Zhichao
    Zhang, Zhengyang
    Zhong, Qihong
    Jiang, Youhua
    Xu, Liwei
    Li, Xiaoyang
    Qian, Dong
    Ma, Dehua
    Ye, Minhua
    Wang, Chunguo
    Wang, Zimin
    Lin, Jiangbo
    Tian, Ziqiang
    Leng, Xuefeng
    Li, Zhigang
    JAMA SURGERY, 2025,
  • [24] Gene expression analysis predicts the pathological response of esophageal squamous cell carcinomas to neoadjuvant chemoradiotherapy
    Yang, Guoqing
    Wang, Qingfang
    Hu, Dongsheng
    Wang, Qingfang
    Yu, Xuejun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (03): : 2032 - 2040
  • [25] Exploration of Multiomic Profiles and Biomarkers as Predictors of Neoadjuvant Chemoradiotherapy Responsiveness in Esophageal Squamous Cell Carcinoma
    Li, Y.
    Liu, J.
    Wang, G. Z.
    Yu, W.
    Cai, X.
    Li, H.
    Cheng, Y.
    Song, X. Y.
    Fu, X. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E315 - E315
  • [26] Prognostic Impact of Inflammation-Based Factors in Patients with Esophageal Squamous Cell Carcinoma Achieving Pathological Complete Response After Neoadjuvant Chemoradiotherapy Followed by Surgery
    Kim, Ji Yong
    Yun, Jea Kwang
    Kim, Yong-Hee
    Park, Seung-il
    Lee, Jeong Hoon
    Jung, Hwoon-Yong
    Lee, Gin Hyug
    Song, Ho June
    Kim, Do Hoon
    Choi, Kee Don
    Ahn, Ji Yong
    Kim, Sung-Bae
    Cho, Kyung-Ja
    Ryu, Jin-Sook
    Kim, Jong Hoon
    Kang, Jihoon
    Park, Sook Ryun
    Kim, Hyeong Ryul
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (10) : 6662 - 6672
  • [27] Pretreatment Primary Tumor Stage is a Risk Factor for Recurrence in Patients with Esophageal Squamous Cell Carcinoma Who Achieve Pathological Complete Response After Neoadjuvant Chemoradiotherapy
    Roberta La Mendola
    Maria Bencivenga
    Lorena Torroni
    Luca Alberti
    Michele Sacco
    Francesco Casella
    Cecilia Ridolfi
    Nicola Simoni
    Renato Micera
    Michele Pavarana
    Giuseppe Verlato
    Simone Giacopuzzi
    Annals of Surgical Oncology, 2021, 28 : 3034 - 3043
  • [28] Pretreatment Primary Tumor Stage is a Risk Factor for Recurrence in Patients with Esophageal Squamous Cell Carcinoma Who Achieve Pathological Complete Response After Neoadjuvant Chemoradiotherapy
    La Mendola, Roberta
    Bencivenga, Maria
    Torroni, Lorena
    Alberti, Luca
    Sacco, Michele
    Casella, Francesco
    Ridolfi, Cecilia
    Simoni, Nicola
    Micera, Renato
    Pavarana, Michele
    Verlato, Giuseppe
    Giacopuzzi, Simone
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (06) : 3034 - 3043
  • [29] A three-lncRNA signature of pretreatment biopsies predicts pathological response and outcome in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapy
    Zhang, Chaoqi
    Zhang, Zhihui
    Zhang, Guochao
    Xue, Liyan
    Yang, Haijun
    Luo, Yuejun
    Zheng, Xiaoli
    Zhang, Yonglei
    Yuan, Yufen
    Lei, Ruixue
    Yang, Zhaoyang
    Zheng, Bo
    Zhang, Zhen
    Wang, Le
    Che, Yun
    Wang, Sihui
    Wang, Feng
    Fang, Lingling
    Zeng, Qingpeng
    Li, Jiagen
    Gao, Shugeng
    Xue, Qi
    Sun, Nan
    He, Jie
    CLINICAL AND TRANSLATIONAL MEDICINE, 2020, 10 (04):
  • [30] Clinicopathologic factors predicting complete pathological response to neoadjuvant chemoradiotherapy in esophageal cancer
    MacGuill, M.
    Mulligan, E.
    Ravi, N.
    Rowley, S.
    Byrne, P. J.
    Hollywood, D.
    Kennedy, J.
    Keeling, P. N.
    Reynolds, J. V.
    DISEASES OF THE ESOPHAGUS, 2006, 19 (04) : 273 - 276
12345